Número total de visitas
| Visualizaciones | |
|---|---|
| External ... | 99 |
Visitas al mes
| junio 2025 | julio 2025 | agosto 2025 | septiembre 2025 | octubre 2025 | noviembre 2025 | diciembre 2025 | |
|---|---|---|---|---|---|---|---|
| External ... | 3 | 1 | 10 | 1 | 2 | 11 | 6 |
Visitas al fichero
| Visualizaciones | |
|---|---|
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021.pdf | 72 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari6.pdf | 41 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari8.pdf | 20 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari2.pdf | 16 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari1.pdf | 15 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari4.pdf | 14 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari3.pdf | 13 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari7.pdf | 13 |
| external_validity_docetaxel_triplet_trials_advanced_gastric_cancer_are_there_patients_who_still_benefit_2021_material_suplementari5.pdf | 10 |
Países con más visualizaciones
| Visualizaciones | |
|---|---|
| Estados Unidos | 37 |
| Singapur | 18 |
| China | 13 |
| Alemania | 10 |
| España | 7 |
| Austria | 3 |
| Brasil | 3 |
| Iraq | 2 |
| Bangladesh | 1 |
| Ecuador | 1 |
Ciudades con más visualizaciones
| Visualizaciones | |
|---|---|
| Singapore | 14 |
| Beijing | 9 |
| Ashburn | 5 |
| Boydton | 4 |
| Social Circle | 3 |
| Almont | 2 |
| Baghdad | 2 |
| Frankfurt am Main | 2 |
| Los Angeles | 2 |
| Nuremberg | 2 |



